A systematic review and economic model of the effectiveness and ...

142
References
213. Lewis D, Linder S, Kurlan R, Winner P, Dunn D,
Sallee FR, et al. Atomoxetine for the treatment of
attention deficit hyperactivity disorder and
comorbid tics in children. Ann Neurol 2003;54
(Suppl 7):S106.
214. Li X, Chen Z. Clinical comparative observation on
duodongning and Ritalin in treating child
hyperkinetic syndrome. Zhongguo Zhong Xi Yi Jie
He Za Zhi 1999;19:410–11.
215. Lieberman SG, Christophersen ER. The effect of
an afternoon dose of methylphenidate on the
accuracy and on-tack behavior of the homework
completed by children with attention deficit
hyperactivity disorder. Pediatr Res 2000;47:29A.
216. Loo SK, Specter E, Smolen A, Hopfer C,
Teale PD, Reite ML. Functional effects of the
DAT1 polymorphism on EEG measures in ADHD.
J Am Acad Child Adolesc Psychiatry 2003;42:986–93.
217. Lopez F, Silva R, Pestreich L, Muniz R.
Comparative efficacy of two once daily
methylphenidate formulations (Ritalin LA and
Concerta) and placebo in children with attention
deficit hyperactivity disorder across the school day.
Paediatr Drugs 2003;5:545–55.
218. Malone MA, Rosenfield JD, Roberts SW.
Methylphenidate (Ritalin) effects on the graphomotor
artwork of children with attention deficit
hyperactivity disorder. Canadian Art Therapy
Association Journal 2002;15:7–13.
219. Mannuzza S, Klein RG, Moulton JL III. Does
stimulant treatment place children at risk for adult
substance abuse? A controlled, prospective followup
study. J Child Adolesc Psychopharmacol
2003;13:273–82.
220. Manos MJ, Short EJ, Findling RL. Dose response
curves across ADHD subtypes: differential effects
between Adderall and methylphenidate. Pediatr
Res 2000;47:172.
221. McBurnett K. Treatment of adolescent ADHD with
OROS ® methylphenidate. Pediatr Res
2003;53:3143.
222. Michelson D, Faries D, Wernicke J, Spencer T.
Atomoxetine in the treatment of children with
ADHD: a randomized, placebo-controlled, doseresponse
study. Eur Neuropsychopharmacol
2001;11:S319.
223. Michelson D, Faries DE, Wernicke JF, Spencer T.
Atomoxetine in the treatment of children with
ADHD: a randomized, placebo-controlled doseresponse
study. Eur Neuropsychopharmacol
2001;11:S319–20.
224. Mohammadi MR, Kashani L, Akhondzadeh S,
Izadian ES, Ohadinia S. Efficacy of theophylline
compared to methylphenidate for the treatment of
attention-deficit hyperactivity disorder in children
and adolescents: a pilot double-blind randomized
trial. J Clin Pharm Ther 2004;29:139–44.
225. Montiel Nava C, Pena JA, Espina Marines G,
Ferrer-Hernandez ME, Lopez-Rubio A, Puertas-
Sanchez S, et al. A pilot study of methylphenidate
and parent training in the treatment of children
with attention-deficit hyperactivity disorder. Rev
Neurol 2002;35:201–5.
226. Newcorn JH. Atomoxetine in the treatment of
children and adolescents with attentiondeficit/hyperactivity
disorder: a randomized,
placebo-controlled dose–response study. Curr
Psychiatry Rep 2003;5:85.
227. Nolan EE, Gadow KD, Sprafkin J. Stimulant
medication withdrawal during long-term therapy
in children with comorbid attention-deficit
hyperactivity disorder and chronic multiple tic
disorder. Pediatrics 1999;103:730–7.
228. Overtoom CC, Verbaten MN, Kemner C,
Kenemans JL, van Engeland H, Buitelaar JK, et al.
Effects of methylphenidate, desipramine, and Ldopa
on attention and inhibition in children with
attention deficit hyperactivity disorder. Behav Brain
Res 2003;145:7–15.
229. Palumbo DR, Starr HL. Impact of ADHD
treatment with a once-daily OROS ® formulation of
methylphenidate on tics. Pediatr Res 2003;
53:555A–6A.
230. Pearson DA, Santos CW, Roache JD, Casat CD,
Loveland KA, Lachar D, et al. Treatment effects of
methylphenidate on behavioral adjustment in
children with mental retardation and ADHD. J Am
Acad Child Adolesc Psychiatry 2003;42:209–16.
231. Pearson DA, Lane DM, Santos CW, Casat CD,
Jerger SW, Loveland KA, et al. Effects of
methylphenidate treatment in children with
mental retardation and ADHD: individual
variation in medication response. J Am Acad Child
Adolesc Psychiatry 2004;43:686–98.
232. Pearson DA, Santos CW, Casat CD, Lane DM,
Jerger SW, Roache JD, et al. Treatment effects of
methylphenidate on cognitive functioning in
children with mental retardation and ADHD. J Am
Acad Child Adolesc Psychiatry 2004;43:677–85.
233. Pelham WE, Hoza B, Pillow DR, Gnagy EM, Kipp
HL, Greiner AR, et al. Effects of methylphenidate
and expectancy on children with ADHD: behavior,
academic performance, and attributions in a
summer treatment program and regular classroom
settings. J Consult Clin Psychol 2002;70:320–35.
234. Rapport MD, Randall R, Moffitt C. Attentiondeficit/hyperactivity
disorder and
methylphenidate: a dose–response analysis and
parent-child comparison of somatic complaints.
J Attention Disord 2002;6:15–24.